USANA Health Sciences, Inc. (NYSE:USNA) is expected to report third quarter earnings results, after market close, on Tuesday 20th October 2020.
Analysts polled by Thomson Reuters anticipate third quarter income of $ 1.25 per share.
Looking ahead, the full year income are expected at $ 5.18 per share on the revenues of $ 1084.81 million.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 1,050.00 million ~ $ 1,100.00 million, where as bottomline are predicted in a range of $ 4.70 ~ $ 5.25 per share
Click Here For More Historical Outlooks Of USANA Health Sciences, Inc.
Previous Quarter Performance
USANA Health Sciences, Inc. unfold income for the second quarter of $ 1.32 per share, from the revenue of $ 258.99 million. The quarterly earnings swell 45.05 percent compared with the same quarter last year. The consensus estimates are income of $ 1.08 per share from $ 256.33 million in revenue. The bottom line results beat street analysts by $ 0.24 or 22.22 percent, at the same time, top line results outshined analysts by $ 2.66 million or 1.04 percent.
Stock Performance
Shares of USANA Health Sciences, Inc. traded up $ 0.42 or 0.54 percent on Monday, reaching $ 77.54 with volume of 98.20 thousand shares. USANA Health Sciences, Inc. has traded high as $ 79.24 and has cracked $ 77.32 on the downward trend
According to the previous trading day, closing price of $ 77.54, representing a 79.31 % increase from the 52 week low of $ 43.01 and a 16.41 % decrease over the 52 week high of $ 92.26.
The company has a market capital of $ 1.63 billion and is part of the Consumer Defensive sector and Household & Personal Products industry.
Conference Call
USANA Health Sciences, Inc. will be hosting a conference call at 11:00 AM eastern time on 21st October 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.usana.com
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition.
